Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide. 2010

Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
Correspondence and offprint requests to: Gheun-Ho Kim; E-mail: kimgh@hanyang.ac.kr.

BACKGROUND Cyclophosphamide is an alkylating agent and was traditionally known to potentiate the renal action of vasopressin. Although low-dose intravenous pulse cyclophosphamide therapy is being used extensively in the treatment of malignant and rheumatological diseases, there have been only a few case reports of cyclophosphamide-induced hyponatraemia. METHODS Clinical data were retrospectively analysed from 84 patients (42 lupus nephritis; 42 non-Hodgkin's lymphoma; a total of 112 treatment episodes) admitted for intravenous pulse cyclophosphamide (500-750 mg/m(2)) therapy. In all patients, half-isotonic saline was used for prophylactic hydration. Cyclophosphamide-induced hyponatraemia was defined as serum sodium concentration <135 mEq/L at 24 hours after the therapy in patients whose basal serum sodium concentrations were normal. RESULTS After the low-dose intravenous pulse cyclophosphamide, serum sodium concentration significantly decreased from 139.9 +/- 3.5 to 137.9 +/- 5.1 mEq/L (P < 0.001). Cyclophosphamide-induced hyponatraemia occurred in 15 treatment episodes (13.4%) from 12 patients (14.3%). Patients with hyponatraemia were significantly older than those without hyponatraemia (57.3 +/- 14.7 vs. 40.0 +/- 17.0 years, P < 0.01). Hyponatraemia was associated with male sex on univariate analysis (P < 0.05), but not on multivariate analysis. No factors were found to independently predict the occurrence of cyclophosphamide-induced hyponatraemia when multivariate analysis was performed including parameters age, sex, underlying disease, presence or absence of comorbidities associated with hyponatraemia, presence or absence of concurrent medications associated with hyponatraemia and dose of cyclophosphamide. CONCLUSIONS Hyponatraemia occurring after low-dose intravenous pulse cyclophosphamide is not rare, especially when hypotonic solutions are adopted for hydration protocol. Thus, the use of hypotonic fluids should be avoided when using cyclophosphamide. Instead, isotonic solutions should be used if a forced diuresis is required.

UI MeSH Term Description Entries
D007010 Hyponatremia Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed) Hyponatremias
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
October 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
December 1989, Postgraduate medical journal,
Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
April 2011, The Netherlands journal of medicine,
Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
March 2022, BMJ case reports,
Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
September 1993, Internal medicine (Tokyo, Japan),
Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
January 2013, The American journal of case reports,
Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
March 2000, The American journal of gastroenterology,
Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
January 2004, Nephron. Clinical practice,
Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
January 2003, Lupus,
Young-Chul Lee, and Joon-Sung Park, and Chang Hwa Lee, and Sang-Cheol Bae, and In-Soon Kim, and Chong Myung Kang, and Gheun-Ho Kim
January 1999, Archives of dermatology,
Copied contents to your clipboard!